Before my session, I felt pain and soreness. Afterward, I enjoyed the feeling of having less pain. I had great sleep that night and felt relaxed.
Dr. Mewissen is a vascular and interventional radiologist recognized by his peers as a world-renowned specialist in the endovascular treatment of patients who suffer from lower limb ischemia and as an expert in the use of stents in the femoral-popliteal arterial segment. He is also one of the pioneers in the endovascular treatment of complex abdominal aortic aneurysms. Dr. Mewissen has demonstrated exceptional dedication to clinical research and is currently the primary investigator for over 10 trials at Aurora St. Luke’s. He recently received the Aurora Health Care Clinical Trial Research award.
In addition to his research and clinical activities, he has published widely in such prestigious journals as Radiology, The Journal of Vascular Surgery and the Journal of Vascular and Interventional Radiology. Dr. Mewissen has also helped train future physicians through teaching positions at the Medical College of Wisconsin in Milwaukee. There, he served as Associate Professor of Radiology and Assistant Professor of Radiology. Having invented several of the tools commonly used by vascular specialists, his many innovations have advanced the discipline.
We are excited to have him as part of the Cryofit team and to support and advance our discipline.
Outlining Benefits of NAD+ Therapy Through Data
Dr. Mewissen shares about his role in Cryofit as the medical director. He personally signs off on the prescriptions for each patient and is available for medical questions. He discusses the benefits of NAD+ therapy and how they track the health of patients that underwent the therapy. Cryofit closely supervises their patients’ progress and hopes to use that data to outline all of the benefits others would receive from NAD+ therapy.